日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

WNT/β-catenin regulatory roles on PD-(L)1 and immunotherapy responses

WNT/β-catenin 在 PD-(L)1 和免疫治疗反应中的调控作用

Mortezaee, Keywan

Extracellular vesicle-based drug delivery in cancer immunotherapy

细胞外囊泡介导的药物递送在癌症免疫治疗中的应用

Najafi, Sajad; Majidpoor, Jamal; Mortezaee, Keywan

Transforming growth factor-β signalling in tumour resistance to the anti-PD-(L)1 therapy: Updated

转化生长因子-β信号通路在肿瘤对PD-(L)1抗体疗法的耐药性中的作用:最新进展

Mortezaee, Keywan; Majidpoor, Jamal

Anti-PD-(L)1 therapy of non-small cell lung cancer-A summary of clinical trials and current progresses

非小细胞肺癌的抗PD-(L)1疗法——临床试验及最新进展概述

Mortezaee, Keywan; Majidpoor, Jamal

Alternative immune checkpoints in immunoregulatory profile of cancer stem cells

癌症干细胞免疫调节谱中的替代免疫检查点

Mortezaee, Keywan; Majidpoor, Jamal

Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications

白细胞介素-6在SARS-CoV-2感染疾病中的作用:相互作用和治疗应用

Majidpoor, Jamal; Mortezaee, Keywan

CD8(+) T Cells in SARS-CoV-2 Induced Disease and Cancer-Clinical Perspectives

CD8(+) T 细胞在 SARS-CoV-2 诱发疾病和癌症中的作用——临床视角

Mortezaee, Keywan; Majidpoor, Jamal

Roles for macrophage-polarizing interleukins in cancer immunity and immunotherapy

巨噬细胞极化白细胞介素在癌症免疫和免疫治疗中的作用

Mortezaee, Keywan; Majidpoor, Jamal

Checkpoint inhibitor/interleukin-based combination therapy of cancer

癌症的检查点抑制剂/白细胞介素联合疗法

Mortezaee, Keywan; Majidpoor, Jamal

Angiogenesis as a hallmark of solid tumors - clinical perspectives

血管生成是实体瘤的标志性特征——临床视角

Majidpoor, Jamal; Mortezaee, Keywan